[1]
“Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome”, IJKD, vol. 12, no. 1, pp. 27–32, Jan. 2018, Accessed: Jul. 11, 2025. [Online]. Available: https://ijkd.org/index.php/ijkd/article/view/3317